baum, and L. Montagnier. 1983. Isolation of a T-lymphocyte retrovirus from
a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 28.
220:868–871.
2. Belman, A. L., M. Ultmann, D. Kurtzberg, and B. Cone-Wesson. 1985.
Neurological complications in children with AIDS. Ann. Neurol. 18:560–566. 29.
3. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and tat-induced expression of the human
immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139–149. 30.
4. Bhat, N. K., R. J. Fisher, S. Fujiwara, R. Ascione, and T. S. Papas. 1987.
Temporal and tissue-specific expression of mouse ets genes. Proc. Natl.
Acad. Sci. USA 84:3161–3165.
5. Brenneman, D. E., G. L. Westbrook, S. P. Fitzgerald, D. L. Ennist, K. L. 31.
Elkins, M. R. Ruff, and C. B. Pert. 1988. Neuronal cell killing by the envelope
protein of HIV and its prevention by vasoactive intestinal peptide. Nature 32.
(London) 335:639–642.
6. Burtis, K. C., C. S. Thummel, C. W. Jones, F. D. Karim, and D. S. Hogness.
1990. The Drosophila 74EF early puff contains E74, a complex ecdysoneinducible gene that encodes two ets-related proteins. Cell 61:85–99.
7. Buzy, J. M., L. M. Linstrom, M. C. Zink, and J. E. Clements. 1995. HIV-1 33.
in the developing CNS: developmental differences in gene expression. Vi- rology 210:361–371.
8. Cartwright, I. L., and S. E. Kelly. 1991. Probing the nature of chromosomal
DNA-protein contacts by in vivo footprinting. BioTechniques 11:188–203. 34.
9. Cauley, K., and I. M. Verma. 1994. kB enhancer-binding complexes that do
not contain NF-kB are developmentally regulated in mammalian brain. Proc.
Natl. Acad. Sci. USA 91:390–394. 35.
10. Corboy, J. R., J. M. Buzy, M. C. Zink, and J. E. Clements. 1992. Expression
directed from HIV long terminal repeats in the central nervous system of 36.
transgenic mice. Science 258:1804–1808.
11. de Fagagna, F. D., G. Marzio, M. I. Gutierrez, L. Y. Kang, A. Falaschi, and
M. Giacca. 1995. Molecular and functional interactions of transcription 37.
factor USF with the long terminal repeat of human immunodeficiency virus
type 1. J. Virol. 69:2765–2775.
12. Demarchi, F., P. D'Agaro, A. Falaschi, and M. Giacca. 1993. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at 38.
the long terminal repeat of human immunodeficiency virus type 1. J. Virol.
67:7450–7460.
13. Dreyer, E. B., P. K. Kaiser, J. T. Offermann, and S. A. Lipton. 1990. HIV-1
coat protein neurotoxicity prevented by calcium channel antagonists. Science 39.
248:365–367.
14. Duan, L., I. Ozaki, J. W. Oakes, J. P. Taylor, K. Khalili, and R. J. Pomerantz. 1994. The tumor suppressor protein p53 strongly alters human immu- 40.
nodeficiency virus type 1 replication. J. Virol. 68:4302–4313.
15. Epstein, L. G., L. R. Sharer, V. V. Joshi, M. M. Fogjas, M. R. Koenigshengin,
and J. M. Oleske. 1985. Progressive encephalopathy in children with ac- quired immunodeficiency syndrome. Ann. Neurol. 17:488–496. 41.
16. Felber, B. K., and G. N. Pavlakis. 1993. Molecular biology of HIV-1: positive
and negative regulatory elements important for virus expression. AIDS
7:S51–S62.
17. Gabuzda, D. H., D. D. Ho, S. M. de la Monte, M. S. Hirsch, T. R. Rota, R. A.
Sobel. 1986. Immunohistochemical identification of HTLV-III antigen in 42.
brains of patients with AIDS. Ann. Neurol. 20:289–295.
18. Gaillard, C., and F. Strauss. 1990. Sequence-specific single-strand-binding
protein for the simian virus 40 early promoter stimulates transcription in 43.
vitro. J. Mol. Biol. 215:245–255.
19. Gallo, R. C., S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F.
Haynes, T. J. Palker, R. Redfield, J. Oleske, B. Safai, G. White, P. Foster,
and P. D. Markham. 1984. Frequent detection and isolation of cytopathic 44.
retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
Science 224:500–503.
20. Garcia, J. A., K. W. Foon, R. Mitsuyasu, and R. B. Gaynor. 1987. Interac- 45.
tions of cellular proteins involved in the transcriptional regulation of the
human immunodeficiency virus. EMBO J. 6:3761–3770.
21. Gartner, S., P. Markovits, D. M. Markovitz, R. F. Betts, and M. Popovic. 46.
1986. Virus isolation from and identification of HTLV-III/LAV-producing
cells in brain tissue from a patient with AIDS. JAMA 256:2365–2371.
22. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of 47.
HIV-1 gene expression. AIDS 6:343–363.
23. Gerster, T., P. Matthias, M. Thali, J. Jiricny, and W. Schaffner. 1987. Cell
type-specific elements of the immunoglobulin heavy chain gene enhancer. 48.
EMBO J. 6:1323–1330.
24. Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid 49.
enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185–196.
25. Greenblatt, J. 1991. Roles of TF II D in transcriptional initiation by RNA 50.
polymerase II. Cell 66:1067–1070.
26. Gualberto, A., and A. S. Baldwin. 1995. p53 and Sp1 interact and cooperate
in the tumor necrosis factor-induced transcriptional activation of the HIV-1
long terminal repeat. J. Biol. Chem. 270:19680–19683. 51.
27. Gunther, C. V., J. A. Nye, R. S. Bryner, and B. J. Graves. 1990. Sequencespecific DNA binding of proto-oncoprotein ets-1 defines a transcriptional 52.
activator sequence within the long terminal repeat of the Moloney murine
